Ameritas Investment Partners, Inc. Dynavax Technologies Corp Transaction History
Ameritas Investment Partners, Inc.
- $2.86 Billion
- Q1 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 12,878 shares of DVAX stock, worth $144,619. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,878
Previous 12,878
-0.0%
Holding current value
$144,619
Previous $180,000
11.67%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding DVAX
# of Institutions
269Shares Held
132MCall Options Held
326KPut Options Held
758K-
Black Rock Inc. New York, NY23.2MShares$260 Million0.01% of portfolio
-
State Street Corp Boston, MA10.6MShares$119 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.4MShares$106 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.14MShares$103 Million3.75% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA7.99MShares$89.7 Million0.23% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.42B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...